A Body Shape Index (ABSI) achieves better mortality risk stratification than alternative indices of abdominal obesity: results from a large European cohort.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 09 2020
Historique:
received: 12 02 2020
accepted: 06 08 2020
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 9 3 2021
Statut: epublish

Résumé

Abdominal and general adiposity are independently associated with mortality, but there is no consensus on how best to assess abdominal adiposity. We compared the ability of alternative waist indices to complement body mass index (BMI) when assessing all-cause mortality. We used data from 352,985 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) and Cox proportional hazards models adjusted for other risk factors. During a mean follow-up of 16.1 years, 38,178 participants died. Combining in one model BMI and a strongly correlated waist index altered the association patterns with mortality, to a predominantly negative association for BMI and a stronger positive association for the waist index, while combining BMI with the uncorrelated A Body Shape Index (ABSI) preserved the association patterns. Sex-specific cohort-wide quartiles of waist indices correlated with BMI could not separate high-risk from low-risk individuals within underweight (BMI < 18.5 kg/m

Identifiants

pubmed: 32883969
doi: 10.1038/s41598-020-71302-5
pii: 10.1038/s41598-020-71302-5
pmc: PMC7471961
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14541

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 24390
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom

Références

Afshin, A. et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med. 377, 13–27 (2017).
doi: 10.1056/NEJMoa1614362
Hill, J. H., Solt, C. & Foster, M. T. Obesity associated disease risk: the role of inherent differences and location of adipose depots. Horm. Mol. Biol. Clin. Investig. https://doi.org/10.1515/hmbci-2018-0012 (2018).
doi: 10.1515/hmbci-2018-0012 pubmed: 29547393
Ding, C., Chan, Z. & Magkos, F. Lean, but not healthy: the “metabolically obese, normal-weight” phenotype. Curr. Opin. Clin. Nutr. Metab. Care 19, 408–417 (2016).
doi: 10.1097/MCO.0000000000000317
Iacobini, C., Pugliese, G., Blasetti Fantauzzi, C., Federici, M. & Menini, S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism. 92, 51–60 (2019).
Schulze, M. B. Metabolic health in normal-weight and obese individuals. Diabetologia 62, 558–566 (2019).
doi: 10.1007/s00125-018-4787-8
Stefan, N., Haring, H. U., Hu, F. B. & Schulze, M. B. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 1, 152–162 (2013).
doi: 10.1016/S2213-8587(13)70062-7
Pischon, T. et al. General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med. 359, 2105–2120 (2008).
doi: 10.1056/NEJMoa0801891
Aune, D. et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30..3 million participants. BMJ 353, i2156. https://doi.org/10.1136/bmj.i2156 (2016).
doi: 10.1136/bmj.i2156 pubmed: 27146380 pmcid: 4856854
Flegal, K. M., Kit, B. K., Orpana, H. & Graubard, B. I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309, 71–82 (2013).
doi: 10.1001/jama.2012.113905
Ashwell, M., Mayhew, L., Richardson, J. & Rickayzen, B. Waist-to-height ratio is more predictive of years of life lost than body mass index. PLoS ONE 9, e103483. https://doi.org/10.1371/journal.pone.0103483 (2014).
doi: 10.1371/journal.pone.0103483 pubmed: 25198730 pmcid: 4157748
Guerrero-Romero, F. & Rodriguez-Moran, M. Abdominal volume index. An anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch. Med. Res. 34, 428–432 (2003).
Ofstad, A. P. et al. Comparison of the associations between non-traditional and traditional indices of adiposity and cardiovascular mortality: an observational study of one million person-years of follow-up. Int. J. Obes. (Lond.) 43, 1082–1092 (2019).
doi: 10.1038/s41366-019-0353-9
Park, Y., Kim, N. H., Kwon, T. Y. & Kim, S. G. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci. Rep. 8, 16753. https://doi.org/10.1038/s41598-018-35073-4 (2018).
doi: 10.1038/s41598-018-35073-4 pubmed: 30425288 pmcid: 6233180
Thomas, D. M. et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring) 21, 2264–2271 (2013).
doi: 10.1002/oby.20408
Valdez, R. A simple model-based index of abdominal adiposity. J. Clin. Epidemiol. 44, 955–956 (1991).
doi: 10.1016/0895-4356(91)90059-I
Woolcott, O. O. & Bergman, R. N. Relative fat mass (RFM) as a new estimator of whole-body fat percentage horizontal line A cross-sectional study in American adult individuals. Sci. Rep. 8, 10980. https://doi.org/10.1038/s41598-018-29362-1 (2018).
doi: 10.1038/s41598-018-29362-1 pubmed: 30030479 pmcid: 6054651
Carmienke, S. et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. Eur. J. Clin. Nutr. 67, 573–585 (2013).
doi: 10.1038/ejcn.2013.61
WHO, Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8–11 December 2008. . Technical report., World Health Organization ISBN 978 92 4 150149 1 (2011).
NICE, 1. Obesity: identification, assessment and management: Recommendations. National Institute for Health and Care Excellence, https://www.nice.org.uk/guidance/cg189/chapter/1-Recommendations (2014).
Ardern, C. I., Janssen, I., Ross, R. & Katzmarzyk, P. T. Development of health-related waist circumference thresholds within BMI categories. Obes. Res. 12, 1094–1103 (2004).
doi: 10.1038/oby.2004.137
Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196 (2015).
doi: 10.1038/nature14132
Krakauer, N. Y. & Krakauer, J. C. A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index. PLoS ONE 7, e39504. https://doi.org/10.1371/journal.pone.0039504 (2012).
doi: 10.1371/journal.pone.0039504 pubmed: 22815707 pmcid: 3399847
Klingenberg, C. P. Size, shape, and form: concepts of allometry in geometric morphometrics. Dev. Genes Evol. 226, 113–137 (2016).
doi: 10.1007/s00427-016-0539-2
Shingleton, A. Allometry: The Study of Biological Scaling. Nature Education Knowledge 3, 2; https://www.nature.com/scitable/knowledge/library/allometry-the-study-of-biological-scaling-13228439 (2010).
Eknoyan, G. Adolphe Quetelet (1796–1874)—the average man and indices of obesity. Nephrol. Dial. Transplant. 23, 47–51 (2008).
doi: 10.1093/ndt/gfm517
Dhana, K. et al. Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality. J. Epidemiol. Community Health 70, 90–96 (2016).
doi: 10.1136/jech-2014-205257
Grant, J. F., Chittleborough, C. R., Shi, Z. & Taylor, A. W. The association between A Body Shape Index and mortality: Results from an Australian cohort. PLoS ONE 12, e0181244. https://doi.org/10.1371/journal.pone.0181244 (2017).
doi: 10.1371/journal.pone.0181244 pubmed: 28759582 pmcid: 5536270
Song, X. et al. Cardiovascular and all-cause mortality in relation to various anthropometric measures of obesity in Europeans. Nutr. Metab. Cardiovasc. Dis. 25, 295–304 (2015).
doi: 10.1016/j.numecd.2014.09.004
Lee, D. Y., Lee, M. Y. & Sung, K. C. Prediction of Mortality with A Body Shape Index in Young Asians: Comparison with Body Mass Index and Waist Circumference. Obesity (Silver Spring) 26, 1096–1103 (2018).
doi: 10.1002/oby.22193
Ji, M., Zhang, S. & An, R. Effectiveness of A Body Shape Index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis. Obes. Rev. 19, 737–759 (2018).
doi: 10.1111/obr.12666
Sato, Y. et al. Body shape index: Sex-specific differences in predictive power for all-cause mortality in the Japanese population. PLoS ONE 12, e0177779. https://doi.org/10.1371/journal.pone.0177779 (2017).
doi: 10.1371/journal.pone.0177779 pubmed: 28520811 pmcid: 5433760
Sardarinia, M., Ansari, R., Azizi, F., Hadaegh, F. & Bozorgmanesh, M. Mortality prediction of a body shape index versus traditional anthropometric measures in an Iranian population: Tehran Lipid and Glucose Study. Nutrition. 33, 105–112 (2017).
doi: 10.1016/j.nut.2016.05.004
Thomson, C. A. et al. Body shape, adiposity index, and mortality in postmenopausal women: Findings from the Women’s Health Initiative. Obesity (Silver Spring) 24, 1061–1069 (2016).
doi: 10.1002/oby.21461
Krakauer, N. Y. & Krakauer, J. C. An Anthropometric Risk Index based on combining height, weight, waist, and hip measurements. J. Obes. 2016, 8094275. https://doi.org/10.1155/2016/8094275 (2016).
doi: 10.1155/2016/8094275 pubmed: 27830087 pmcid: 5088335
Haftenberger, M. et al. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 5, 1147–1162 (2002).
doi: 10.1079/PHN2002396
Riboli, E. et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 5, 1113–1124 (2002).
doi: 10.1079/PHN2002394
Wareham, N. J. et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6, 407–413 (2003).
doi: 10.1079/PHN2002439
Hothorn, T., Bretz, F. & Westfall, P. Simultaneous inference in general parametric models. Biom. J. 50, 346–363 (2008).
doi: 10.1002/bimj.200810425
Zeileis, A. & Hothorn, T. Diagnostic Checking in Regression Relationships. R News. 2/3, 7–10; https://cran.r-project.org/doc/Rnews/Rnews_2002-3.pdf (2002).
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria https://www.R-project.org/(2017 ).
Heitmann, B. L. & Lissner, L. Hip Hip Hurrah! Hip size inversely related to heart disease and total mortality. Obes. Rev. 12, 478–481 (2011).
doi: 10.1111/j.1467-789X.2010.00794.x
Rost, S. et al. New indexes of body fat distribution and sex-specific risk of total and cause-specific mortality: a prospective cohort study. BMC Public Health. 18, 427. https://doi.org/10.1186/s12889-018-5350-8 (2018).
doi: 10.1186/s12889-018-5350-8 pubmed: 29609587 pmcid: 5879745
Sahakyan, K. R. et al. Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann. Intern. Med. 163, 827–835 (2015).
doi: 10.7326/M14-2525
Gomez-Peralta, F. et al. Relationship between “a body shape index (ABSI)” and body composition in obese patients with type 2 diabetes. Diabetol. Metab. Syndr. 10, 21. https://doi.org/10.1186/s13098-018-0323-8 (2018).
doi: 10.1186/s13098-018-0323-8 pubmed: 29568333 pmcid: 5859756
Consalvo, V. et al. ABSI (A Body Shape Index) and ARI (Anthropometric Risk Indicator) in Bariatric Surgery. First Application on a Bariatric Cohort and Possible Clinical Use. Obes. Surg. 28, 1966–1973 (2018).
Hoermann, R., Fui, M. N. T., Krakauer, J. C., Krakauer, N. Y. & Grossmann, M. A body shape index (ABSI) reflects body composition changes in response to testosterone treatment in obese men. Int. J. Obes. (Lond.) 43, 2210–2216 (2019).
doi: 10.1038/s41366-018-0311-y
Krakauer, N. Y. & Krakauer, J. C. Untangling Waist Circumference and Hip Circumference from Body Mass Index with a Body Shape Index, Hip Index, and Anthropometric Risk Indicator. Metab. Syndr. Relat. Disord. 16, 160–165 (2018).
doi: 10.1089/met.2017.0166
Kloting, N. et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 299, E506-515 (2010).
doi: 10.1152/ajpendo.00586.2009
Stefan, N. et al. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168, 1609–1616 (2008).
doi: 10.1001/archinte.168.15.1609
Chrousos, G. P. & Gold, P. W. A healthy body in a healthy mind—and vice versa—the damaging power of “uncontrollable” stress. J. Clin. Endocrinol. Metab. 83, 1842–1845 (1998).
pubmed: 9626106
Foster, M. T. So as we worry we weigh: visible burrow system stress and visceral adiposity. Physiol. Behav. 178, 151–156 (2017).
doi: 10.1016/j.physbeh.2017.01.019
Pasquali, R., Vicennati, V., Cacciari, M. & Pagotto, U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann. N. Y. Acad. Sci. 1083, 111–128 (2006).
doi: 10.1196/annals.1367.009

Auteurs

Sofia Christakoudi (S)

Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, St Mary's Campus, London, W2 1PG, UK. s.christakoudi@imperial.ac.uk.
MRC Centre for Transplantation, King's College London, Great Maze Pond, London, SE1 9RT, UK. s.christakoudi@imperial.ac.uk.

Konstantinos K Tsilidis (KK)

Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, St Mary's Campus, London, W2 1PG, UK.
Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, 45100, Ioannina, Greece.

David C Muller (DC)

Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, St Mary's Campus, London, W2 1PG, UK.

Heinz Freisling (H)

International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon CEDEX 08, France.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon CEDEX 08, France.

Kim Overvad (K)

Department of Public Health, Aarhus University, DK-8000, Aarhus, Denmark.
Department of Cardiology, Aalborg University Hospital, DK-9000, Aalborg, Denmark.

Stefan Söderberg (S)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Christel Häggström (C)

Department of Biobank Research, Umeå University, Umeå, Sweden.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Tobias Pischon (T)

Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany.
Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Christina C Dahm (CC)

Department of Public Health, Aarhus University, DK-8000, Aarhus, Denmark.

Jie Zhang (J)

Department of Public Health, Aarhus University, DK-8000, Aarhus, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100, Copenhagen Ø, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Jytte Halkjær (J)

Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100, Copenhagen Ø, Denmark.

Conor MacDonald (C)

Centre de recherche en Epidemiologie et Sante des Populations (CESP), Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, 94805, Villejuif, France.
Gustave Roussy, F-94805, Villejuif, France.

Marie-Christine Boutron-Ruault (MC)

Centre de recherche en Epidemiologie et Sante des Populations (CESP), Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, 94805, Villejuif, France.
Gustave Roussy, F-94805, Villejuif, France.

Francesca Romana Mancini (FR)

Centre de recherche en Epidemiologie et Sante des Populations (CESP), Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, 94805, Villejuif, France.
Gustave Roussy, F-94805, Villejuif, France.

Tilman Kühn (T)

German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.

Rudolf Kaaks (R)

German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.

Eleni Peppa (E)

Hellenic Health Foundation, Athens, Greece.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.

Valeria Pala (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian, 1, 20133, Milan, Italy.

Salvatore Panico (S)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Azienda Sanitaria Provinciale Ragusa (ASP), Ragusa, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

J Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Maria-Jose Sánchez (MJ)

Andalusian School of Public Health (EASP), Granada, Spain.
Instituto de Investigación Biosanitaria de Granada ibs.GRANADA, Granada, Spain.
Universidad de Granada, Granada, Spain.
CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Lluís Cirera (L)

CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB - Arrixaca, Murcia, Spain.
Department of Health and Social Sciences, University of Murcia, Murcia, Spain.

Aurelio Barricarte-Gurrea (A)

CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA) Pamplona, Pamplona, Spain.

Pilar Amiano (P)

CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain.

Ensieh Memarian (E)

Dept. Clinical Sciences, Skane University Hospital, Lund University, 20502, Malmö, Sweden.

Emily Sonestedt (E)

Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Bas Bueno-de-Mesquita (B)

Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, St Mary's Campus, London, W2 1PG, UK.
Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.
Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Pantai Valley, 50603, Kuala Lumpur, Malaysia.

Anne M May (AM)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, STR 6.131, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.

Kay-Tee Khaw (KT)

School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 2QQ, UK.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, Institute of Metabolic Science, School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK.

Tammy Y N Tong (TYN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Inge Huybrechts (I)

International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon CEDEX 08, France.

Hwayoung Noh (H)

International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon CEDEX 08, France.

Elom K Aglago (EK)

International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon CEDEX 08, France.

Merete Ellingjord-Dale (M)

Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, St Mary's Campus, London, W2 1PG, UK.

Heather A Ward (HA)

Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, St Mary's Campus, London, W2 1PG, UK.

Dagfinn Aune (D)

Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, St Mary's Campus, London, W2 1PG, UK.
Department of Nutrition, Bjørknes University College, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Elio Riboli (E)

Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, St Mary's Campus, London, W2 1PG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH